ArticleBMJ (Clinical research ed.)2003

"Polypill" to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable.

Andrea Messori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.